カテゴリー： QYResearch, 世界, 医療/バイオ

世界の二重特異性＆三重特異性抗体市場インサイト及び予測（二重特異性抗体、三重特異性抗体）

◆英語タイトル：Global Bispecific and Trispecific Antibody Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX09208）◆商品コード：QY22JLX09208
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、二重特異性＆三重特異性抗体のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に二重特異性＆三重特異性抗体の世界市場のxxx％を占める「二重特異性抗体」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「癌」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
二重特異性＆三重特異性抗体の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの二重特異性＆三重特異性抗体市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

二重特異性＆三重特異性抗体のグローバル主要企業には、AbbVie、Affimed、Biotheus、Biontech、Genmab、GT Biopharma、Harpoon Therapeutics、MacroGenics、Numab、Sanofi、Sichuan Baili Pharmaceuticals、Roche、Amgen、Pfizer、Johnson & Johnson、AstraZenecaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

二重特異性＆三重特異性抗体市場は、種類と用途によって区分されます。世界の二重特異性＆三重特異性抗体市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
二重特異性抗体、三重特異性抗体

【用途別セグメント】
癌、血友病、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 二重特異性＆三重特異性抗体製品概要
- 種類別市場（二重特異性抗体、三重特異性抗体）
- 用途別市場（癌、血友病、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の二重特異性＆三重特異性抗体販売量予測2017-2028
- 世界の二重特異性＆三重特異性抗体売上予測2017-2028
- 二重特異性＆三重特異性抗体の地域別販売量
- 二重特異性＆三重特異性抗体の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別二重特異性＆三重特異性抗体販売量
- 主要メーカー別二重特異性＆三重特異性抗体売上
- 主要メーカー別二重特異性＆三重特異性抗体価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（二重特異性抗体、三重特異性抗体）
- 二重特異性＆三重特異性抗体の種類別販売量
- 二重特異性＆三重特異性抗体の種類別売上
- 二重特異性＆三重特異性抗体の種類別価格
・用途別市場規模（癌、血友病、その他）
- 二重特異性＆三重特異性抗体の用途別販売量
- 二重特異性＆三重特異性抗体の用途別売上
- 二重特異性＆三重特異性抗体の用途別価格
・北米市場
- 北米の二重特異性＆三重特異性抗体市場規模（種類別、用途別）
- 主要国別の二重特異性＆三重特異性抗体市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの二重特異性＆三重特異性抗体市場規模（種類別、用途別）
- 主要国別の二重特異性＆三重特異性抗体市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の二重特異性＆三重特異性抗体市場規模（種類別、用途別）
- 主要国別の二重特異性＆三重特異性抗体市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の二重特異性＆三重特異性抗体市場規模（種類別、用途別）
- 主要国別の二重特異性＆三重特異性抗体市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの二重特異性＆三重特異性抗体市場規模（種類別、用途別）
- 主要国別の二重特異性＆三重特異性抗体市場規模（トルコ、サウジアラビア）
・企業情報
AbbVie、Affimed、Biotheus、Biontech、Genmab、GT Biopharma、Harpoon Therapeutics、MacroGenics、Numab、Sanofi、Sichuan Baili Pharmaceuticals、Roche、Amgen、Pfizer、Johnson & Johnson、AstraZeneca
・産業チェーン及び販売チャネル分析
- 二重特異性＆三重特異性抗体の産業チェーン分析
- 二重特異性＆三重特異性抗体の原材料
- 二重特異性＆三重特異性抗体の生産プロセス
- 二重特異性＆三重特異性抗体の販売及びマーケティング
- 二重特異性＆三重特異性抗体の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 二重特異性＆三重特異性抗体の産業動向
- 二重特異性＆三重特異性抗体のマーケットドライバー
- 二重特異性＆三重特異性抗体の課題
- 二重特異性＆三重特異性抗体の阻害要因
・主な調査結果

Market Analysis and Insights: Global Bispecific and Trispecific Antibody Market
The global Bispecific and Trispecific Antibody market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Bispecific Antibody accounting for % of the Bispecific and Trispecific Antibody global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period.
China Bispecific and Trispecific Antibody market size is valued at US$ million in 2021, while the North America and Europe Bispecific and Trispecific Antibody are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bispecific and Trispecific Antibody landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bispecific and Trispecific Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bispecific and Trispecific Antibody market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bispecific and Trispecific Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bispecific and Trispecific Antibody market.
Global Bispecific and Trispecific Antibody Scope and Market Size
Bispecific and Trispecific Antibody market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Bispecific and Trispecific Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bispecific Antibody
Trispecific Antibody
Segment by Application
Cancer
Haemophilia
Others
By Company
AbbVie
Affimed
Biotheus
Biontech
Genmab
GT Biopharma
Harpoon Therapeutics
MacroGenics
Numab
Sanofi
Sichuan Baili Pharmaceuticals
Roche
Amgen
Pfizer
Johnson & Johnson
AstraZeneca
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific and Trispecific Antibody Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bispecific Antibody
1.2.3 Trispecific Antibody
1.3 Market by Application
1.3.1 Global Bispecific and Trispecific Antibody Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bispecific and Trispecific Antibody Market Perspective (2017-2028)
2.2 Bispecific and Trispecific Antibody Growth Trends by Region
2.2.1 Bispecific and Trispecific Antibody Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Bispecific and Trispecific Antibody Historic Market Size by Region (2017-2022)
2.2.3 Bispecific and Trispecific Antibody Forecasted Market Size by Region (2023-2028)
2.3 Bispecific and Trispecific Antibody Market Dynamics
2.3.1 Bispecific and Trispecific Antibody Industry Trends
2.3.2 Bispecific and Trispecific Antibody Market Drivers
2.3.3 Bispecific and Trispecific Antibody Market Challenges
2.3.4 Bispecific and Trispecific Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bispecific and Trispecific Antibody Players by Revenue
3.1.1 Global Top Bispecific and Trispecific Antibody Players by Revenue (2017-2022)
3.1.2 Global Bispecific and Trispecific Antibody Revenue Market Share by Players (2017-2022)
3.2 Global Bispecific and Trispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bispecific and Trispecific Antibody Revenue
3.4 Global Bispecific and Trispecific Antibody Market Concentration Ratio
3.4.1 Global Bispecific and Trispecific Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific and Trispecific Antibody Revenue in 2021
3.5 Bispecific and Trispecific Antibody Key Players Head office and Area Served
3.6 Key Players Bispecific and Trispecific Antibody Product Solution and Service
3.7 Date of Enter into Bispecific and Trispecific Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bispecific and Trispecific Antibody Breakdown Data by Type
4.1 Global Bispecific and Trispecific Antibody Historic Market Size by Type (2017-2022)
4.2 Global Bispecific and Trispecific Antibody Forecasted Market Size by Type (2023-2028)
5 Bispecific and Trispecific Antibody Breakdown Data by Application
5.1 Global Bispecific and Trispecific Antibody Historic Market Size by Application (2017-2022)
5.2 Global Bispecific and Trispecific Antibody Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bispecific and Trispecific Antibody Market Size (2017-2028)
6.2 North America Bispecific and Trispecific Antibody Market Size by Type
6.2.1 North America Bispecific and Trispecific Antibody Market Size by Type (2017-2022)
6.2.2 North America Bispecific and Trispecific Antibody Market Size by Type (2023-2028)
6.2.3 North America Bispecific and Trispecific Antibody Market Share by Type (2017-2028)
6.3 North America Bispecific and Trispecific Antibody Market Size by Application
6.3.1 North America Bispecific and Trispecific Antibody Market Size by Application (2017-2022)
6.3.2 North America Bispecific and Trispecific Antibody Market Size by Application (2023-2028)
6.3.3 North America Bispecific and Trispecific Antibody Market Share by Application (2017-2028)
6.4 North America Bispecific and Trispecific Antibody Market Size by Country
6.4.1 North America Bispecific and Trispecific Antibody Market Size by Country (2017-2022)
6.4.2 North America Bispecific and Trispecific Antibody Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bispecific and Trispecific Antibody Market Size (2017-2028)
7.2 Europe Bispecific and Trispecific Antibody Market Size by Type
7.2.1 Europe Bispecific and Trispecific Antibody Market Size by Type (2017-2022)
7.2.2 Europe Bispecific and Trispecific Antibody Market Size by Type (2023-2028)
7.2.3 Europe Bispecific and Trispecific Antibody Market Share by Type (2017-2028)
7.3 Europe Bispecific and Trispecific Antibody Market Size by Application
7.3.1 Europe Bispecific and Trispecific Antibody Market Size by Application (2017-2022)
7.3.2 Europe Bispecific and Trispecific Antibody Market Size by Application (2023-2028)
7.3.3 Europe Bispecific and Trispecific Antibody Market Share by Application (2017-2028)
7.4 Europe Bispecific and Trispecific Antibody Market Size by Country
7.4.1 Europe Bispecific and Trispecific Antibody Market Size by Country (2017-2022)
7.4.2 Europe Bispecific and Trispecific Antibody Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bispecific and Trispecific Antibody Market Size (2017-2028)
8.2 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Type
8.2.1 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Bispecific and Trispecific Antibody Market Share by Type (2017-2028)
8.3 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Application
8.3.1 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Bispecific and Trispecific Antibody Market Share by Application (2017-2028)
8.4 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region
8.4.1 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bispecific and Trispecific Antibody Market Size (2017-2028)
9.2 Latin America Bispecific and Trispecific Antibody Market Size by Type
9.2.1 Latin America Bispecific and Trispecific Antibody Market Size by Type (2017-2022)
9.2.2 Latin America Bispecific and Trispecific Antibody Market Size by Type (2023-2028)
9.2.3 Latin America Bispecific and Trispecific Antibody Market Share by Type (2017-2028)
9.3 Latin America Bispecific and Trispecific Antibody Market Size by Application
9.3.1 Latin America Bispecific and Trispecific Antibody Market Size by Application (2017-2022)
9.3.2 Latin America Bispecific and Trispecific Antibody Market Size by Application (2023-2028)
9.3.3 Latin America Bispecific and Trispecific Antibody Market Share by Application (2017-2028)
9.4 Latin America Bispecific and Trispecific Antibody Market Size by Country
9.4.1 Latin America Bispecific and Trispecific Antibody Market Size by Country (2017-2022)
9.4.2 Latin America Bispecific and Trispecific Antibody Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bispecific and Trispecific Antibody Market Size (2017-2028)
10.2 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Type
10.2.1 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Bispecific and Trispecific Antibody Market Share by Type (2017-2028)
10.3 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Application
10.3.1 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Bispecific and Trispecific Antibody Market Share by Application (2017-2028)
10.4 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country
10.4.1 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Bispecific and Trispecific Antibody Introduction
11.1.4 AbbVie Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.1.5 AbbVie Recent Developments
11.2 Affimed
11.2.1 Affimed Company Details
11.2.2 Affimed Business Overview
11.2.3 Affimed Bispecific and Trispecific Antibody Introduction
11.2.4 Affimed Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.2.5 Affimed Recent Developments
11.3 Biotheus
11.3.1 Biotheus Company Details
11.3.2 Biotheus Business Overview
11.3.3 Biotheus Bispecific and Trispecific Antibody Introduction
11.3.4 Biotheus Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.3.5 Biotheus Recent Developments
11.4 Biontech
11.4.1 Biontech Company Details
11.4.2 Biontech Business Overview
11.4.3 Biontech Bispecific and Trispecific Antibody Introduction
11.4.4 Biontech Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.4.5 Biontech Recent Developments
11.5 Genmab
11.5.1 Genmab Company Details
11.5.2 Genmab Business Overview
11.5.3 Genmab Bispecific and Trispecific Antibody Introduction
11.5.4 Genmab Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.5.5 Genmab Recent Developments
11.6 GT Biopharma
11.6.1 GT Biopharma Company Details
11.6.2 GT Biopharma Business Overview
11.6.3 GT Biopharma Bispecific and Trispecific Antibody Introduction
11.6.4 GT Biopharma Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.6.5 GT Biopharma Recent Developments
11.7 Harpoon Therapeutics
11.7.1 Harpoon Therapeutics Company Details
11.7.2 Harpoon Therapeutics Business Overview
11.7.3 Harpoon Therapeutics Bispecific and Trispecific Antibody Introduction
11.7.4 Harpoon Therapeutics Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.7.5 Harpoon Therapeutics Recent Developments
11.8 MacroGenics
11.8.1 MacroGenics Company Details
11.8.2 MacroGenics Business Overview
11.8.3 MacroGenics Bispecific and Trispecific Antibody Introduction
11.8.4 MacroGenics Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.8.5 MacroGenics Recent Developments
11.9 Numab
11.9.1 Numab Company Details
11.9.2 Numab Business Overview
11.9.3 Numab Bispecific and Trispecific Antibody Introduction
11.9.4 Numab Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.9.5 Numab Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Bispecific and Trispecific Antibody Introduction
11.10.4 Sanofi Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.10.5 Sanofi Recent Developments
11.11 Sichuan Baili Pharmaceuticals
11.11.1 Sichuan Baili Pharmaceuticals Company Details
11.11.2 Sichuan Baili Pharmaceuticals Business Overview
11.11.3 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Introduction
11.11.4 Sichuan Baili Pharmaceuticals Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.11.5 Sichuan Baili Pharmaceuticals Recent Developments
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Bispecific and Trispecific Antibody Introduction
11.12.4 Roche Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.12.5 Roche Recent Developments
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Bispecific and Trispecific Antibody Introduction
11.13.4 Amgen Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.13.5 Amgen Recent Developments
11.14 Pfizer
11.14.1 Pfizer Company Details
11.14.2 Pfizer Business Overview
11.14.3 Pfizer Bispecific and Trispecific Antibody Introduction
11.14.4 Pfizer Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.14.5 Pfizer Recent Developments
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Bispecific and Trispecific Antibody Introduction
11.15.4 Johnson & Johnson Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.15.5 Johnson & Johnson Recent Developments
11.16 AstraZeneca
11.16.1 AstraZeneca Company Details
11.16.2 AstraZeneca Business Overview
11.16.3 AstraZeneca Bispecific and Trispecific Antibody Introduction
11.16.4 AstraZeneca Revenue in Bispecific and Trispecific Antibody Business (2017-2022)
11.16.5 AstraZeneca Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の二重特異性＆三重特異性抗体市場インサイト及び予測（二重特異性抗体、三重特異性抗体）(Global Bispecific and Trispecific Antibody Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 迅速抗原/抗体検出キットのグローバル市場2023年：迅速抗原検査、迅速抗体検査
  • 抗体開発サービスのグローバル市場2023年：モノクローナル抗体開発、ポリクローナル抗体開発
  • 世界の抗体検査プラットフォーム市場インサイト及び予測（抗原設計、ヒット作製、リード選択、リード最適化、リード特性評価、その他）
  • 世界のAFMポリクローナル抗体市場インサイト及び予測（ヤギ、ロバ、ウサギ、ラット、その他）
  • 世界の新型コロナウイルス感染症抗体迅速検査キット市場インサイト及び予測（IgG検査、IgM検査、その他）